Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer

Annals of Internal Medicine

Volumn 135, Issue 8 II, 2001, Pages 577-588

  Ramsey, S D ^a   Clarke, L ^a   Etzioni, R ^a   Higashi, M ^a   Berry, K ^a   Urban, N ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SCREENING; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL;

EID: 0035899935     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-135-8_part_1-200110160-00008     Document Type: Article

References (60)

1. A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden
2. Dominant genes for colorectal cancer are not rare
3. Descriptive epidemiology of hereditary non-polyposis colorectal cancer
4. Hereditary colorectal cancer
5. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer
6. Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility, adopted on February 20, 1996
7. Surveillance in hereditary nonpolyposis colorectal cancer: An international cooperative study of 165 families
8. A National Cancer Institute Workshop on hereditary nonpolyposis colorectal cancer syndrome: Meeting highlights and Bethesda guidelines
9. Identification of concurrent germ-line mutations in hMSH2 and/or hMLH1 in Japanese hereditary nonpolyposis colorectal cancer kindreds
10. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer
11. Population-based molecular detection of hereditary nonpolyposis colorectal cancer
12. The genetics of hereditary non-polyposis colorectal cancer and non-polypotic colon cancer
13. A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer
14. 2000 Update of American Society of Clinical Oncology colorectal cancer surveillance guidelines
15. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer
16. Disclosing genetic information to family members. Do old paradigms fit the new medicine?
17. Genetic testing: Do healthcare professionals have a duty to tell a patient's family members that they may be at risk?
18. Whose genes are these anyway?: Familial conflicts over access to genetic information
19. Genomic torts: The law of the future - The duty of physicians to disclose the presence of a genetic disease to the relatives of their patients with the disease
20. Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: Implications for clinical predisposition testing
21. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients
22. Microsatellite instability and the role of hMSH2 in sporadic colorectal cancer
23. Genomic instability in colorectal cancer: Relationship to clinicopathological variables and family history
24. Standardized approach for microsatellite instability detection in colorectal carcinomas
25. Hereditary non-polyposis colorectal cancer: Clinical features and survival. Results from the Danish HNPCC register
26. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer
27. Survival analysis in families affected by hereditary non-polyposis colorectal cancer
28. Use of colonoscopy to screen asymptomatic adults for colorectal cancer
29. Complications in endoscopy of the lower gastrointestinal tract. Therapy and prognosis
30. Selective management of colonoscopic perforations
31. Description of diagnostic techniques
32. Towards safer colonoscopy: A report on the complications of 5000 diagnostic or therapeutic colonoscopies
33. Curative resection for left colonic carcinoma: Hemicolectomy vs. segmental colectomy. A prospective, controlled, multicenter trial
34. The endorectal ileal pullthrough procedure in patients with ulcerative colitis and familial polyposis with carcinoma
35. A personal experience with 100 consecutive total colectomies and straight ileoanal endorectal pull-throughs for benign disease of the colon and rectum in children and adults
36. A prospective study of mortality associated with anaesthesia and surgery: Risk indicators of mortality in hospital
37. Interest in genetic testing for colon cancer susceptibility: Cognitive and emotional correlates
38. Interest in genetic testing among first-degree relatives of colorectal cancer patients
39. Genetic testing falls short of public embrace
40. Genetic testing in families with hereditary nonpolyposis colon cancer
41. Billing and record-keeping for familial cancer risk counseling: A national survey
42. Potential for cancer related health services research using a linked Medicare-tumor registry database
43. Estimating the costs attributable to a disease with application to ovarian cancer
44. The use of gene tests to detect hereditary predisposition to cancer: Economic considerations
45. Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer. Part I: Studies of cancer in families
46. Genetic counseling for families with inherited susceptibility to breast and ovarian cancer
47. Psychological issues in genetic testing for breast cancer susceptibility
48. Psychosocial impact of genetic testing in familial medullarythyroid carcinoma: A multicentric pilot-evaluation
49. Life-time risk of different cancers in hereditary non-pulyposis colorectal cancer (HNPCC) syndrome
50. Cancer risk in mutation carriers of DNA-mismatch-repair genes
51. Hereditary nonpolyposis colorectal cancer